Evaluation of the Clinicoradiological Profile in Cases of Allergic Bronchopulmonary Aspergillosis: An Original Research.
Allergic bronchopulmonary aspergillosis
Allergies
Asthma
Drug resistance
Journal
Journal of pharmacy & bioallied sciences
ISSN: 0976-4879
Titre abrégé: J Pharm Bioallied Sci
Pays: India
ID NLM: 101537209
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
18
10
2022
revised:
11
01
2023
accepted:
20
02
2023
medline:
1
9
2023
pubmed:
1
9
2023
entrez:
1
9
2023
Statut:
ppublish
Résumé
A complicated hypersensitive reaction to inhaled fungal antigens results in allergic bronchopulmonary aspergillosis (ABPA), an immunologic pulmonary disease. ABPA complicates nearly 2% of instances of persistent asthma as well as nearly 10% of chronic cases of steroid-dependent asthma, and it occurs most frequently in immunocompetent patients. The purpose of the current research was to analyze the radiological and clinical features of the participants as well as the serological association of ABPA. From April 2020 to April 2021, a retrospective investigation was conducted. The study included patients based on the A total of 50 patients were investigated at in this study. Demographic findings indicated young subjects and aa female predominance. Cough was the most prevalent symptom in 84% of patients. Asthma of the bronchi was a risk factor for all of the patients. The mean serum immunoglobulin E level and the mean absolute eosinophil count were 533 cells/L and 2269 UI/mL, respectively. Spirometry results from the study's participants indicated an obstructive pattern in about 80% of cases. The most typical radiological abnormality observed was bronchiectasis, followed by parenchymal opacities. In conclusion, when treating asthma that is challenging to control, the diagnosis of ABPA must be taken into account. Delay in diagnosis might result in declining lung function, worsening asthma control, possibly irreversible alterations, greater treatment costs, and declined quality of life.
Identifiants
pubmed: 37654414
doi: 10.4103/jpbs.jpbs_496_22
pii: JPBS-15-285
pmc: PMC10466558
doi:
Types de publication
Journal Article
Langues
eng
Pagination
S285-S287Informations de copyright
Copyright: © 2023 Journal of Pharmacy and Bioallied Sciences.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Int J Tuberc Lung Dis. 2009 Aug;13(8):936-44
pubmed: 19723372
Clin Chest Med. 2012 Jun;33(2):265-81
pubmed: 22640845
Chest. 2009 Mar;135(3):805-826
pubmed: 19265090
J Allergy Clin Immunol. 2002 Nov;110(5):685-92
pubmed: 12417875
Lung India. 2010 Oct;27(4):209-11
pubmed: 21139716
Int J Infect Dis. 2010 Jun;14(6):e479-82
pubmed: 19910234
Clin Infect Dis. 2003 Oct 1;37 Suppl 3:S265-80
pubmed: 12975754
Expert Rev Respir Med. 2016 Dec;10(12):1317-1334
pubmed: 27744712
Indian J Med Microbiol. 2001 Oct-Dec;19(4):201-5
pubmed: 17664833
Indian J Med Microbiol. 2002 Jul-Sep;20(3):141-4
pubmed: 17657053